Form 13-F position report

REGENERON PHARMACEUTICALS

Reported by SOUTHEASTERN ASSET MANAGEMENT INC TN

REGN CUSIP 75886F107 Manager CIK 0000807985

Reported 144,607 shares, down 15,974 (9.9%) from the prior quarter.

Reported value -3.6%; share count -9.9% vs. the prior quarter.

Reduced
% of reported 13F value 4.15% This manager · Q3 2025
Shares 144,607 Quarter-end amount reported
Reported value $81,308,178 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-03-31 72860344
2025-06-30 84305025
2025-09-30 81308178
2025-12-31 127969871
2026-03-31 100954687
2026-06-30 94978860

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for REGENERON PHARMACEUTICALS held by SOUTHEASTERN ASSET MANAGEMENT INC TN.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 152,322 +21,660 (16.6%) 4.95% $94,978,860 2026-08-14
Q1 2026 Reduced 130,662 -35,130 (-21.2%) 4.97% $100,954,687 2026-05-15
Q4 2025 Added 165,792 +21,185 (14.7%) 5.7% $127,969,871 2026-02-13
Q3 2025 Reduced 144,607 -15,974 (-9.9%) 4.15% $81,308,178 2025-11-14
Q2 2025 Added 160,581 +45,701 (39.8%) 4.25% $84,305,025 2025-08-14
Q1 2025 New 114,880 +114,880 (0.0%) 3.88% $72,860,344 2025-05-15

Who else reported the position

1358 managers reported REGENERON PHARMACEUTICALS for Q3 2025.

Managers reporting REGENERON PHARMACEUTICALS in Q3 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 9,048,269 -375,779 0.08% $5,087,570,211 50 qtrs
BlackRock Inc Reduced 8,837,174 -438,911 0.09% $4,968,878,140 5 qtrs
STATE STREET CORPORATION Reduced 4,691,223 -140,779 0.09% $2,637,733,956 50 qtrs
Dodge & Cox Added 4,550,845 +724,562 1.38% $2,558,803,618 16 qtrs
JPMorgan Chase & Co Added 4,072,326 +132,708 0.14% $2,289,760,415 50 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 2,535,898 +70,844 0.09% $1,419,627,369 50 qtrs
FRANKLIN RESOURCES INC Added 2,453,143 +139,647 0.34% $1,379,328,713 50 qtrs
Capital World Investors Added 1,998,366 +32,348 0.15% $1,123,608,855 50 qtrs
LOOMIS SAYLES & CO L P Added 1,979,453 +38,383 1.32% $1,112,987,056 37 qtrs
FMR LLC Reduced 1,935,835 -1,391,216 0.06% $1,088,462,214 50 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2025
Filed
November 14, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
144,607
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.